What are the effects of using Nexplanon (etonogestrel) for more than three years on dizziness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Nexplanon should be replaced with a new implant if you've had it for more than 3 years and are experiencing dizziness, as the effectiveness of the implant may be impaired and hormone levels may be decreasing. When considering the use of Nexplanon for more than three years, it's essential to weigh the potential risks and benefits, particularly in relation to dizziness as a side effect. According to a study published in Pediatrics in 2016 1, the effectiveness of the implant is unchanged at 4 years of use, but changes in menstrual bleeding patterns are the most common side effect, and data on the effect of progestin implants on bone mineral density are scant. Some key points to consider include:

  • The efficacy of progestin implants may be impaired by hepatic enzyme–inducing drugs that act on the cytochrome P450 pathway, as noted in the study 1.
  • Emerging evidence indicates reduced levonorgestrel concentrations in women who use levonorgestrel implants and receive efavirenz‑containing antiretroviral therapy, which may also apply to etonogestrel implants like Nexplanon 1.
  • The National Institutes of Health (NIH) guidance is to use an alternative or additional contraceptive method when efavirenz, nevirapine, or most protease inhibitors (PIs) are administered to HIV‑infected individuals, but the CDC and the World Health Organization (WHO) state that the benefits of using progestin implants outweigh any risks with concomitant administration of an antiretroviral agent in HIV‑infected women 1. Given the potential for decreased hormone levels and impaired effectiveness, replacing the Nexplanon implant with a new one is the most appropriate course of action to ensure consistent hormone levels and effective contraception, and to potentially resolve dizziness related to fluctuating hormone levels.

From the Research

Nexplanon for More Than Three Years and Dizziness

  • There is limited information available on the specific topic of dizziness associated with the use of Nexplanon (etonogestrel implant) for more than three years.
  • However, studies have shown that the etonogestrel implant is a highly effective and safe contraceptive method, with some evidence suggesting that it can be used for up to 5 years without a significant decrease in efficacy 2.
  • A systematic review of the safety and benefits of contraceptive implants, including the etonogestrel implant, found that abnormal menstrual bleeding is a common side effect, but did not mention dizziness as a specific side effect 3.
  • Another study found that the etonogestrel implant is highly effective and safe for up to 5 years, with no pregnancies reported during the additional 2 years of follow-up 2.
  • A review of tips and tricks for the management of the etonogestrel implant in clinical practice did not mention dizziness as a potential side effect 4.
  • A randomized controlled trial found that women with bleeding complaints related to the etonogestrel implant may experience improvement with continuous combined oral contraceptives, but did not mention dizziness as a side effect 5.
  • A systematic review of the clinical effectiveness, side-effect profile, and continuation rate of the etonogestrel implant found that abnormal menstruation is the most commonly reported side effect, but did not mention dizziness 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Safety and Benefits of Contraceptives Implants: A Systematic Review.

Pharmaceuticals (Basel, Switzerland), 2021

Research

Tips and tricks for the management of contraceptive etonogestrel implant in clinical practice: an Expert Opinion.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2024

Research

Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.